3 terminated, 1 completed. 4 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Terminated 3, Completed 1 |
| Phase 2 | 2 | Terminated 2 |
Follow Versartis Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Long-Term Safety Study of Somavaratan in Japanese Children With Growth Hormone Deficiency Somavaratan - Growth Hormone Deficiency | Phase 3 | Terminated | Versartis Inc. | 21 | 2017-03-31 | 2018-03-09 |
| Long-Acting Growth Hormone in Children Compared to Daily rhGH Somavaratan, rhGH - Growth Disorders | Phase 3 | Completed | Versartis Inc. | 138 | 2015-08-26 | 2022-12-30 |
| Versartis Trial in Pre-pubertal Japanese Children With Growth Hormone Deficiency (GHD) to Assess Long-Acting Growth Hormone (Somavaratan, VRS-317) Somavaratan (VRS-317) - Pediatric Growth Hormone Deficiency, Growth Disorders | Phase 2 / Phase 3 | Terminated | Versartis Inc. | 41 | 2015-08-08 | 2022-07-25 |
| Versartis Long-Term Safety Study of Somavaratan somavaratan - Pediatric Growth Hormone Deficiency | Phase 2 / Phase 3 | Terminated | Versartis Inc. | 385 | 2014-03-03 | 2018-03-09 |
Dwarfism, Pituitary (3) · Growth Disorders (3) · Dwarfism (1) · Failure to Thrive (1)
Japan (1) · United States (1)